These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 35619893)

  • 1. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression.
    Wu Q; Zhou L; Lv D; Zhu X; Tang H
    J Hematol Oncol; 2019 May; 12(1):53. PubMed ID: 31142326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma.
    Yu Z; Guo J; Liu Y; Wang M; Liu Z; Gao Y; Huang L
    J Nanobiotechnology; 2022 Jan; 20(1):9. PubMed ID: 34983554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
    Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
    Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
    Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
    J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options.
    Sas Z; Cendrowicz E; Weinhäuser I; Rygiel TP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma.
    Yin Z; Dong C; Jiang K; Xu Z; Li R; Guo K; Shao S; Wang L
    J Hematol Oncol; 2019 Sep; 12(1):101. PubMed ID: 31547836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells.
    Huang H; Tsui YM; Ng IO
    Cell Mol Gastroenterol Hepatol; 2023; 15(5):1105-1116. PubMed ID: 36736664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-stromal nanotherapeutics for hepatocellular carcinoma.
    Yu Z; Huang L; Guo J
    J Control Release; 2024 Mar; 367():500-514. PubMed ID: 38278367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.
    Chen C; Wang Z; Ding Y; Qin Y
    Front Immunol; 2023; 14():1133308. PubMed ID: 36845131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.
    Li H
    Dig Liver Dis; 2022 May; 54(5):598-613. PubMed ID: 34344577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma.
    Wang X; Hassan W; Jabeen Q; Khan GJ; Iqbal F
    Cytokine; 2018 Mar; 103():150-159. PubMed ID: 29029799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].
    Feng T; Yang X; Wang Q; Liu X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):6-12. PubMed ID: 38322525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression.
    Novikova MV; Khromova NV; Kopnin PB
    Biochemistry (Mosc); 2017 Aug; 82(8):861-873. PubMed ID: 28941454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma.
    Yeung CLS; Yam JWP
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1088-1101. PubMed ID: 35158067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.